Brand check
Is Drotin banned in India?
Last checked 19 September 2026. A few details are still being checked against the original document.
Drotin is not banned in India as of 19 Sep 2026; drotaverine has never been notified under Section 26A, and the CDSCO's 11 Apr 2025 halt concerned a three-drug drotaverine + mefenamic acid + paracetamol product, not Drotin or Drotin-M.
- Classification
- No ban or recall found in official records
- Decided by
- CDSCO / Ministry of Health and Family Welfare
- Reference
- No Section 26A notification for drotaverine; CDSCO direction 11 Apr 2025 covers drotaverine + mefenamic acid + paracetamol
- Latest action
- 11 April 2025
- Last checked
- 19 September 2026details being verified
Drotaverine tablets in a blister pack. Photo: Дротаверин (Drotaverine, Drotaverinum).jpg by Schekinov Alexey Victorovich (CC BY-SA 4.0). Brand names and logos belong to their owners and are used here to identify the product this entry is about. All photo credits.
CDSCO: Drugs banned in India (consumer section)
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Governing authority
- CDSCO, Ministry of Health and Family Welfare
- Ban notification
- None
- Drotin
- Drotaverine 40/80 mg, not banned
- Drotin-M
- Drotaverine + mefenamic acid, not banned
- Halted 11 Apr 2025
- Drotaverine + mefenamic acid + paracetamol (three-drug product)
- Manufacturer
- Walter Bushnell (Drotin)
Where the claim comes from
The 11 April 2025 CDSCO halt of 35 unapproved combinations included drotaverine + mefenamic acid + paracetamol. Reports listed it as a 'drotaverine-mefenamic combination', which describes Drotin-M as well, and both Drotin names were assumed to be affected. The rumour travels with the Meftal-Spas rumour, since the two are prescribed for the same complaints.
Drotin is drotaverine, an antispasmodic used for abdominal and menstrual cramps, and Drotin-M pairs it with the painkiller mefenamic acid. Neither is banned in India.
Drotaverine has never been named in a Section 26A notification. It is not in the CDSCO's list of banned single-ingredient drugs and does not appear in the FDC waves of 2016, 2018, 2023, 2024 or 2026. The two-drug drotaverine + mefenamic acid combination is likewise absent from those lists.
The action that started the question was the CDSCO's direction of 11 April 2025, in which it told state licensing authorities to halt 35 fixed-dose combinations that had been licensed at state level without the central approval required for new drugs. One of the 35 was drotaverine + mefenamic acid + paracetamol, a three-drug product sold by several small manufacturers. Coverage described it as a "drotaverine-mefenamic acid combination", and Drotin-M inherited the description. The plan we work from also flags the legal nature of that April 2025 action, a direction to licensing authorities rather than a Gazette ban, for verification.
For patients, the check is the ingredient list. Drotaverine alone is Drotin; drotaverine with mefenamic acid is Drotin-M; both are fine. Drotaverine with mefenamic acid and paracetamol is the halted product, and a pharmacist can supply the two-drug version and, if needed, paracetamol separately.
What this means for you
Drotin and Drotin-M continue
Both are licensed and can be used as prescribed for cramps and period pain.
Three actives means the halted product
If a pack lists paracetamol with drotaverine and mefenamic acid, ask your pharmacist for the two-drug version instead.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Batches flagged in CDSCO alerts
Products whose name matches this brand or molecule in CDSCO monthly NSQ alerts. A flagged batch is a single batch; the company's response, where reported, is noted on the page above.
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Drotaverine Hydrochloride & Diclofenac Potassium Tablets | KFCR6023Mfg 2026-03 · Exp 2028-02 | Cris Pharma (India) Ltd. E-11Uttarakhand | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab | Jul 2026 |
| Drotaverine Hydrochloride & Mefenamic Acid Tablets | DMR-504Mfg 2026-01 · Exp 2027-12 | Healer?s Lab Unit IIHimachal Pradesh | The sample does not conforms to the claim with respect to description as it show physical instability in the form of Mottling.Description | DTL, UdaipurState lab | Jun 2026 |
| Drotaverine HCL Suspension | L-25244Mfg 2025-10 · Exp 2027-09 | Daffohils Laboratories Pvt.LtdUttarakhand | ContentOther | DTL, Chennai-06State lab | May 2026 |
| Drotaverine Hydrochloride Suspension | OL25619Mfg 2025-11 · Exp 2027-10 | Devbhoomi PharmaceuticalsUttarakhand | That the sample received does not conform to Manufactureres specification with respect to the test for Assay of Drotaverine HydrochlorideAssay | CDTL, MumbaiCDSCO lab | Feb 2026 |
| Drotaverine Hydrochloride Suspension | A20718Mfg 2025-04 · Exp 2027-03 | Aspen Lifescieces PvtPunjab | ContentOther | DTL, Madurai-19State lab | Feb 2026 |
| Drotaverine HCl Suspension PED-DS suspension 60ml | L-250901Mfg 2025-09 · Exp 2030-08 | Dr. Pal's Pharmaceuticals 10B-1Uttarakhand | The sample does not conform to claim with respect to The test for Microbial contamination (Total Aerobic Viable Count and Total Fungal Count).Microbial limits | CDTL, MumbaiCDSCO lab | Dec 2025 |
| Drotaverine Hydrochloride & Mefenamic Acid Tablets (SPASMIC) | UT6035Mfg 2024-05 · Exp 2027-04 | Uttaranchal Pharmaceuticals Pvt Ltd. Kh No. 673Uttarakhand | The Sample does not conform to the claim with respect to colour presence of Quinoline Yellow in place of Erythrosine on label claimLabelling | DTL, JaipurState lab | Oct 2025 |
| Drotaverine Hydrochloride Tablets 40 mg. (Dratovis-40 ) | 12680Mfg 2024-01 · Exp 2026-12 | Syncom Formulations (India) LtdMadhya Pradesh | Assay of Drotaverine HydrochlorideAssay | CDL KolkataCDSCO lab | Feb 2025 |
| Aceclofenac & Drotaverine Hydrochlori de Tablets (100 mg/ 80 mg) | PRT2401 -01Mfg 2024-01 · Exp 2025-12 | Regent Ajanta BiotechUttarakhand | DescriptionDescription | State Lab KarnatakaState lab | Jan 2025 |
| DROTAVERINE HYDROCHLORIDE IP | DTV/170/2021Mfg 2021-10 · Exp 2026-09 | Punjab Chemical & Crop Protection LtdPunjab | Loss on DryingLoss on drying | RDTL ChandigarhCDSCO lab | Dec 2021 |
| Drotaverine Hydrochloride Injection | DTB-003Mfg 2017-10 · Exp 2019-09 | Radico RemediesHimachal Pradesh | Description & Particulate MatterDescription | CDL KolkataCDSCO lab | Jun 2019 |
Official sources and primary records
- Business Today: India halts 35 drug combinations over health risks, full listNewsBusiness Today · 17 April 2025
- Business Standard: CDSCO halts manufacture, sale, distribution of 35 FDCs over safety concernsNewsBusiness Standard · 16 April 2025
- Regulator